Soleno Therapeutics (SLNO) Preferred Dividend Payments (2015 - 2016)
Soleno Therapeutics (SLNO) posted quarterly Preferred Dividend Payments of $3.7 million for Q4 2016, up 219.71% year-over-year from $1.1 million in Q1 2016, and little changed quarter-over-quarter from $3.7 million in Q3 2016.
Soleno Therapeutics (SLNO) Preferred Dividend Payments (2015 - 2016) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Preferred Dividend Payments for 2 consecutive years, with $3.7 million the latest figure, recorded in Q4 2016.
- In Q4 2016, Preferred Dividend Payments rose 219.71% year-over-year to $3.7 million; the TTM figure through Dec 2016 stood at $7.3 million (changed N/A YoY), while the FY2016 annual figure was $3.7 million, changed N/A from the prior year.
- Preferred Dividend Payments was little changed at $3.7 million in Q4 2016 per SLNO's latest filing, from $3.7 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $3.7 million in Q4 2016 and bottomed at -$3.0 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 3.65 Mn |
| Sep 30, 2016 | 3.65 Mn |
| Dec 31, 2015 | -3.05 Mn |
| Mar 31, 2015 | 3.05 Mn |